chr2-29220765-G-T
Variant names: 
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP5
The NM_004304.5(ALK):c.3586C>A(p.Leu1196Met) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L1196P) has been classified as Uncertain significance.
Frequency
 Genomes: not found (cov: 32) 
Consequence
 ALK
NM_004304.5 missense
NM_004304.5 missense
Scores
 3
 10
 6
Clinical Significance
Conservation
 PhyloP100:  6.86  
Publications
763 publications found 
Genes affected
 ALK  (HGNC:427):  (ALK receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011] 
ALK Gene-Disease associations (from GenCC):
- neuroblastoma, susceptibility to, 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
PP5
Variant 2-29220765-G-T is Pathogenic according to our data. Variant chr2-29220765-G-T is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 376135.Status of the report is no_assertion_criteria_provided, 0 stars. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
32
GnomAD4 exome Cov.: 31 
GnomAD4 exome 
Cov.: 
31
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
32
ClinVar
Significance: Likely pathogenic 
Submissions summary: Pathogenic:1 
Revision: no assertion criteria provided
LINK: link 
Submissions by phenotype
Lung cancer    Pathogenic:1 
-
Molekularpathologisches Zentrum, Universitaetsklinikum Heidelberg
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Pathogenic 
 BayesDel_addAF 
 Uncertain 
D 
 BayesDel_noAF 
 Uncertain 
 DANN 
 Uncertain 
 DEOGEN2 
 Benign 
T;T;. 
 Eigen 
 Uncertain 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Pathogenic 
D 
 LIST_S2 
 Benign 
T;T;T 
 M_CAP 
 Benign 
D 
 MetaRNN 
 Uncertain 
D;D;D 
 MetaSVM 
 Uncertain 
D 
 MutationAssessor 
 Benign 
.;N;. 
 PhyloP100 
 PrimateAI 
 Pathogenic 
D 
 PROVEAN 
 Benign 
.;N;. 
 REVEL 
 Uncertain 
 Sift 
 Uncertain 
.;D;. 
 Sift4G 
 Uncertain 
.;D;D 
 Polyphen 
 1.0 
.;D;. 
 Vest4 
 0.79, 0.73 
 MutPred 
 0.61 
.;Loss of sheet (P = 0.0817);.;
 MVP 
 0.87 
 MPC 
 0.69 
 ClinPred 
D 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.